A Phase Iii Efficacy and Safety Study of the Proposed Rituximab Biosimilar Gp2013 Versus Rituximab in Patients with Previously Untreated Advanced Follicular Lymphoma
AuthID
P-00R-BM2
P-00R-BM2
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service